TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ)

CUSIP: 89357L402

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
700,000
Total 13F shares
2,128,495
Share change
+2,118,585
Total reported value
$1,053,827
Price per share
$0.50
Number of holders
15
Value change
+$1,048,922
Number of buys
15

Quarterly Holders Quick Answers

What is CUSIP 89357L402?
CUSIP 89357L402 identifies RNAZ - TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) as of Q1 2025

As of 31 Mar 2025, TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,128,495 shares. The largest 10 holders included Anson Funds Management LP, UBS Group AG, SABBY MANAGEMENT, LLC, Warberg Asset Management LLC, CORSAIR CAPITAL MANAGEMENT, L.P., ACADIAN ASSET MANAGEMENT LLC, COMMONWEALTH EQUITY SERVICES, LLC, SouthState Corp, Ground Swell Capital, LLC, and MORGAN STANLEY. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.